Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence. - Wikidata - wikimedia - TriplyDB

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

http://www.wikidata.org/entity/Q34427649

about

Coexpression and expression quantitative trait loci analyses of the angiogenesis gene-gene interaction network in prostate cancer.Palmatine inhibits growth and invasion in prostate cancer cell: Potential role for rpS6/NFκB/FLIP.Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC.Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.FLIP: molecular switch between apoptosis and necroptosis.Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target.miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1.Natural Products as Mechanism-based Anticancer Agents: Sp Transcription Factors as Targets.Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention.LncRNA HOXA11-AS promotes proliferation and invasion by targeting miR-124 in human non-small cell lung cancer cells.Combination of Nexrutine and docetaxel suppresses NFκB-mediated activation of c-FLIP.

P2860

Q33838280-B7F5AD74-BCEE-4200-84E4-546D3BA62C21 Q34429968-9930C94B-08CC-4B5E-8CF7-C51DD282BB2B Q36413458-4D0EB781-A775-422F-B0B1-CBEA69AEECF7 Q37046523-8A4D8F3C-65C9-49C0-A98D-1A3F0FFC9488 Q37225520-9A485692-8E4B-4D87-9ACD-6A828A2DA3E2 Q38102627-B72A9F87-48EC-4D84-8176-EEFBFA431BEC Q38209122-5129CDC4-93F8-4AD9-B3AC-1748E54BBF2B Q38755682-55708F2D-89FB-4F13-940F-A5FE994A3745 Q38888042-DD60FFF1-3547-45BD-87D3-5E2BFCA08B5B Q38973480-9E03B45E-BFC5-44D3-B0C8-8A2A007FA975 Q47649549-7DB0CFA8-AE60-4607-9766-E01D586F27FF Q48171505-89FE52EA-FCB0-4718-889A-4BF48418E1B8

P2860

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

http://www.wikidata.org/entity/Q34427649

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

@ast

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

@en

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

@nl

type

label

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

@ast

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

@en

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

@nl

prefLabel

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

@ast

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

@en

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

@nl

P1433

Q34427649-27038BBF-244C-41A1-8329-BF81B8B691FC

P1476

Q34427649-8ADF6156-9482-41A4-A384-2894934C51E4

P2093

Q34427649-0205BA24-D5DC-456F-8583-98C0F1FE84A2

Q34427649-06C08E70-57FF-42DD-BE64-2712E2AD61FC

Q34427649-1B4E364E-B37A-4EA6-A735-35AE79EDA2FA

Q34427649-523C4299-D5F3-4B62-BE6A-AF0B966895CF

Q34427649-C2DB1FD5-A0BE-49E4-B5DB-D09D61C3B1E3

Q34427649-E298AF48-4EC7-416D-B43B-12D03992852F

Q34427649-ECEE1400-7100-47A1-9D3A-DF7D2D43C14F

P2860

Q34427649-0290BDC2-C00A-49EB-BD35-09128A5E5417

Q34427649-08BDFFD9-A81B-44E7-A2C2-8B9F331654B9

Q34427649-09137196-356B-4556-BF0F-72B0752D46E4

Q34427649-20ED66FD-EB19-4F28-AB09-9162A85FA6D7

Q34427649-23E22DAE-BA9E-4711-8820-C6AB5D5B5681

Q34427649-27214FAA-B8FF-4B59-9967-067BFBB6F8E5

Q34427649-2ACB3FB0-F1F7-4EB7-A277-4A862A96EB40

Q34427649-36D07DC3-C6D7-450B-929A-B95E24338263

Q34427649-37E3B3A2-D036-460E-8359-E36B06C28068

Q34427649-382AAABB-E053-4CED-99BA-F3DC3F0CCD65

P304

Q34427649-C4EACBBF-2687-44C0-8E68-F228AF72523D

P31

Q34427649-7F3CCACA-03DB-43E1-B606-744C2D32C5AB

P356

Q34427649-38BEFEE3-8A74-4A3C-B6C9-8AFF12176E10

P407

Q34427649-BC505AA6-059C-4767-81EB-4685C4AC5D85

P433

Q34427649-B4EADAF0-B473-4142-BFCB-F1578521E846

P478

Q34427649-DF6C9FDE-F76B-4F7A-8DF3-7CCEA9270D24

P577

Q34427649-4046A67C-5EDD-499F-B657-A6A1AE1F6FFA

P5875

Q34427649-92C5AE07-BC7E-4BC5-8139-C2F08FF2F9CC

P698

Q34427649-453D1318-F225-44B5-930A-0EB6F2D9FB85

P932

Q34427649-3A823C3F-58C6-4CA4-905C-CB23B1A5891A

P356

JOURNAL.PONE.0044917

P1433

P1476

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

@en

P2093

Addanki P Kumar

http://www.w3.org/2001/XMLSchema#string

I-Tien Yeh

http://www.w3.org/2001/XMLSchema#string

Ian M Thompson

http://www.w3.org/2001/XMLSchema#string

Jingjing Gong

http://www.w3.org/2001/XMLSchema#string

Rita Ghosh

http://www.w3.org/2001/XMLSchema#string

Roble G Bedolla

http://www.w3.org/2001/XMLSchema#string

Thomas J Prihoda

http://www.w3.org/2001/XMLSchema#string

P2860

Dual role of Sp3 transcription factor as an inducer of apoptosis and a marker of tumour aggressiveness

Inhibition of death receptor signals by cellular FLIP

Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract

Cancer statistics, 2012

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology.

Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature.

Prostate cancer: PSA screening--more data, more debate.

Emerging biomarkers for prostate cancer diagnosis, staging, and prognosis.

Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription.

P304

e44917

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0044917

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231815022

http://www.w3.org/2001/XMLSchema#string

P698

23028678

http://www.w3.org/2001/XMLSchema#string

P932

3441693

http://www.w3.org/2001/XMLSchema#string